Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginseng for Fatigue in Regorafenib-Treated Colorectal Cancer
NCT02581059Phase 2Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- Apr 2016
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoints: Multidimensional Fatigue Symptom Inventory-Short Form at 8 weeks and Patient-Reported Outcomes Measurement Information System Fatigue at 8 weeks. Started Apr 2016; status: terminated.
Beyond the preview
Go deeper on NCT02581059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02581059.